Characterization of DNA methylation as well as mico-RNA expression and screening of epigenetic markers in adipogenesis

J Transl Med. 2022 Feb 15;20(1):93. doi: 10.1186/s12967-022-03295-w.

Abstract

This study aimed to use bioinformatics methods to characterize epigenetic changes in terms of micro-RNA(miRNA) expression and DNA methylation during adipogenesis. The mRNA and miRNA expression microarray and DNA methylation dataset were obtained from the GEO database. Differentially expressed genes (DEGs), differentially expressed miRNAs (DEMs) and differentially methylated probes (DMPs) were filtered using the limma package. The R language cluster profile package was used for functional and enrichment analysis. A protein-protein interaction (PPI) network was constructed using STRING and visualized in Cytoscape. The Connection map (CMap) website tool was used to screen potential therapeutic drugs for adipogenesis. When comparing the early and late stages of adipogenesis, 111 low miRNA targeted upregulated genes and 64 high miRNA targeted downregulated genes were obtained, as well as 663 low-methylated high-expressed genes and 237 high-methylated low-expressed genes. In addition, 41 genes (24 upregulated and 17 downregulated) were simultaneously regulated by abnormal miRNA changes and DNA methylation. Ten chemicals were identified as putative therapeutics for adipogenesis. In addition, among the dual-regulated genes identified, CANX, HNRNPA1, MCL1, and PPIF may play key roles in the epigenetic regulation of adipogenesis and may serve as aberrant methylation or miRNA targeting biomarkers.

Keywords: Adipogenesis; Epigenetics; Methylation; Micro-RNA.

MeSH terms

  • Adipogenesis / genetics
  • Biomarkers / metabolism
  • Computational Biology / methods
  • DNA Methylation* / genetics
  • Epigenesis, Genetic
  • Gene Expression Profiling
  • Gene Regulatory Networks
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism

Substances

  • Biomarkers
  • MicroRNAs